Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Development of novel anti-tuberculosis combination regimens that increase efficacy and reduce treatment timelines will improve patient compliance, limit side-effects, reduce costs, and enhance cure rates. Such advancements would significantly improve the global TB burden and reduce drug resistance a...
Main Authors: | Erik J. Hasenoehrl, Thomas J. Wiggins, Michael Berney |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2020.611683/full |
Similar Items
-
Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery
by: Iram Khan Iqbal, et al.
Published: (2018-02-01) -
Spontaneous mutational patterns and novel mutations for bedaquiline and clofazimine resistance in Mycobacterium tuberculosis
by: Jin Shi, et al.
Published: (2023-10-01) -
Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages
by: Bridgette M Cumming, et al.
Published: (2018-11-01) -
Uncovering the roles of Mycobacterium tuberculosis melH in redox and bioenergetic homeostasis: implications for antitubercular therapy
by: Yu-Ching Chen, et al.
Published: (2024-04-01) -
Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance Mycobacterium tuberculosis in Shanghai, China
by: Guo Y, et al.
Published: (2023-12-01)